Psilocybin Equals or Exceeds SSRI Antidepressants at Easing Depression

• Dennis Thompson HealthDay Reporter
• September 23, 2024
• Página completa

Psilocybin, the active ingredient in magic mushrooms, appears to ease depression symptoms at least as well as one of the most commonly used antidepressants, a new clinical...

Could Antidepressants Give Memory a Boost?

• Dennis Thompson HealthDay Reporter
• September 23, 2024
• Página completa

Antidepressants have the potential to improve memory and thinking skills, a new study suggests.

Some patients experienced a boost on brain tests after taking the SSR...

Are Antidepressants Being Overused to Treat Seniors' Pain?

• Ernie Mundell HealthDay Reporter
• September 20, 2024
• Página completa

Doctors sometimes turn to antidepressants as a means of easing older people's physical pain, but a new expert review finds there's little evidence to support the practice.

Antidepressants may even come with hazards for seniors who don't need them, said researchers from t...

When It Comes to Weight Gain, Not All Antidepressants Are the Same

• Dennis Thompson HealthDay Reporter
• July 3, 2024
• Página completa

Weight gain is a common side effect of antidepressants, but some types cause people to pack on pounds more than others, a new study says.

Bupropion users are 15% to ...

Slow-Release Ketamine Pill Eases Depression: Study

• Dennis Thompson HealthDay Reporter
• June 25, 2024
• Página completa

A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects normally associated with the drug, early research ...

1 in 6 Patients Who Quit Antidepressants Get 'Discontinuation Symptoms'

• Dennis Thompson HealthDay Reporter
• June 7, 2024
• Página completa

Roughly 1 in 6 people who stop taking an antidepressant will experience symptoms caused by discontinuing the drug, a new review finds.

However, only 1 in 35 will exp...

Quick Withdrawal From Antidepressants Can Take Emotional, Cognitive Toll

• Dennis Thompson HealthDay Reporter
• January 19, 2024
• Página completa

People coming off antidepressants often struggle with emotional and social turmoil, especially if they quit their meds cold turkey, a new study reports.

Challenges reported by patients quitting antidepressants included feeling overwhelmed by their emotions, finding socia...

Postpartum Depression Pill Now Available to Women, Drug Maker Says

• Robin Foster HealthDay Reporter
• December 15, 2023
• Página completa

The first postpartum depression pill approved for use in the United States is now available to women who need it, the drug's makers announced Thursday.

Sold under the name Zurzuvae, the medication can quickly ease severe postpartum depression and help women regain their ...

Ketamine's Antidepressant Benefit: Is It All in Your Head?

• Cara Murez HealthDay Reporter
• October 24, 2023
• Página completa

The party drug ketamine has gotten a lot of notice for its potential to help people with severe and persistent depression who haven't responded to other treatments.

But a new study has discovered the drug's effect may be in the heads of patients who take it.

Resear...

Commonly Used Drug Might Be New Treatment Option for IBS

• Cara Murez HealthDay Reporter
• October 18, 2023
• Página completa

An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS).

In the study, British researchers found that those taking amitriptyli...

Some Antidepressants Take Weeks to Kick In, and Scientists May Now Know Why

• Cara Murez HealthDay Reporter
• October 12, 2023
• Página completa

Most folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.

Scientists have discovered this is because of physical changes in the brain that unfold over those first f...

Running vs. Meds: Which Works Best to Beat Depression?

• Alan Mozes HealthDay Reporter
• October 9, 2023
• Página completa

Exercise has been dubbed "nature's antidepressant" by doctors for years, and now a new study confirms the notion.

The finding follows a four-month look at the impact that running had on anxiety and depression when compared to a common antidepressant.

SSRIs (selecti...

Study Debunks Notion That Antidepressant Might Ease COVID Symptoms

• Cara Murez HealthDay Reporter
• September 18, 2023
• Página completa

A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.

The study, led by Duke Clinical Research Institute (DCRI) in partnership wit...

Antidepressants for Postpartum Depression Could Mean Better Mental Health for Kids, Too

• Cara Murez HealthDay Reporter
• August 30, 2023
• Página completa

If you are a new mom struggling with postpartum depression, taking antidepressants known as selective serotonin reuptake inhibitors (SSRIs) may also bear benefits for your child's development.

That's according to new research that found the medications were associated wi...

Could Ativan Pose Harm to People Battling Pancreatic Cancer?

• Cara Murez HealthDay Reporter
• August 17, 2023
• Página completa

Sometimes patients with pancreatic cancer are prescribed the benzodiazepine lorazepam (Ativan) for anxiety, but that may be harming their health.

A new study found this treatment was linked to worse outcomes, with shorter survival times and faster disease progression. <...

Extended Use of Antidepressants May Help People With Bipolar Depression

• Dennis Thompson HealthDay Reporter
• August 10, 2023
• Página completa

Modern antidepressants could be effective for long-term treatment of some patients with bipolar disorder, a new trial suggests.

Current guidelines discourage use of antidepressants in these patients, over concerns that the drugs will trigger a manic episode.

But bi...

The Most Common Depression Medications, Explained

• Ann Schreiber HealthDay Reporter
• May 26, 2023
• Página completa

You've been diagnosed with depression. What's next?

The cornerstone of treatment remains antidepressants, so it's likely your doctor will prescribe one for you, but which one might be best?

You will join millions around the world who struggle with how to treat the ...

Depression Treatments: Medications, Lifestyle Changes & More

• Ann Schreiber HealthDay Reporter
• May 25, 2023
• Página completa

Depression is a debilitating condition that can leave its millions of sufferers in despair.

Globally, an estimated 5% of adults suffer from depression, according to the World Health Or...

For Seniors on Antidepressants, Adding a Drug May Work Better Than Switching

• Denise Mann HealthDay Reporter
• March 10, 2023
• Página completa

Many older adults with depression don't respond to their first antidepressant, so doctors will switch them to another one to see if that does the trick.

Now, new research suggests that the best strategy for these folks may instead be to add the antipsychotic drug A...

Doctors Often Prescribe Antidepressants for Pain, But Do They Really Work?

• Dennis Thompson HealthDay Reporter
• February 2, 2023
• Página completa

Antidepressants are often prescribed to people suffering from chronic pain, but a new evidence review argues that the science behind these prescriptions is shaky at best.

These drugs helped people in chronic pain in only a quarter of potential uses tested, and even then ...

Depression Treatment Starts Changing the Brain Within 6 Weeks

• Cara Murez HealthDay Reporter
• November 2, 2022
• Página completa

New research reveals that the brain is much more flexible than once thought and can change rapidly during treatment for major depression.

People receiving inpatient treatment for major depression had increased brain connectivity after just six weeks, German researchers r...

Study Debunks Use of Antidepressant Luvox as COVID Treatment

• Cara Murez HealthDay Reporter
• October 20, 2022
• Página completa

A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial smaller dose.

Study participants took 50 mg of the medication twi...

With 'Chemical Imbalance' Theory in Doubt, What's Next for Depression Care?

• Serena McNiff HealthDay Reporter
• September 6, 2022
• Página completa

TUESDAY, Sept. 6, 2022 (HealthDay Now) -- For Mary Christ, the idea that depression is a chemical imbalance in the brain has always felt true to her personal experience.

A former educator, C...

No Link Between Antidepressants in Pregnancy, Epilepsy in Children

• By Robert Preidt HealthDay Reporter
• May 12, 2022
• Página completa

There's good news for women with a mental health condition: Taking antidepressants early in pregnancy doesn't increase a baby's risk of having epilepsy or seizures, researchers say.

"The findings of this study are very important," said study co-author Ayesha Sujan of Ind...

In Long Run, Antidepressants Don't Improve Quality of Life: Study

• Alan Mozes HealthDay Reporter
• April 20, 2022
• Página completa

Millions of Americans take antidepressants to combat low moods. But a large, new study suggests that these medications over time may do little to improve overall quality of life.

"We found the change in health-related quality of life to be comparable or similar between p...

Certain Meds Raise Odds for Delirium After Surgery

• Robert Preidt
• December 13, 2021
• Página completa

Older adults have a higher risk of delirium after hip and knee surgery if they're taking anxiety, depression or insomnia drugs, researchers say.

"Our findings show that different classes of medicine are riskier than others when it comes to causing delirium after surgery,...

Many Psychiatric Patients Are Getting Risky Drug Gabapentin 'Off-Label'

• Amy Norton HealthDay Reporter
• November 22, 2021
• Página completa

Most prescriptions for the medication gabapentin are for unapproved uses -- and many patients end up taking it along with drugs that create potentially dangerous interactions.

That's the conclusion of a new study that looked at "off-label" use of gabapentin. In the Unite...

Certain Antidepressants Appear to Curb Severe COVID-19

• Alan Mozes HealthDay Reporter
• November 15, 2021
• Página completa

Certain commonly prescribed antidepressants appear to substantially lower the risk of dying among seriously ill COVID-19 patients, a large new study indicates.

Selective serotonin reuptake inhibitors (SSRIs) are among the most widely prescribed drugs for the treatment of...

Placebo Effect Plays Big Role in Antidepressant's Impact on Anxiety: Study

• Ernie Mundell and Robert Preidt HealthDay Reporters
• November 10, 2021
• Página completa

Illustrating the power of the mind to heal itself, new research suggests that the placebo effect could help drive antidepressants' effects against anxiety disorders.

The placebo effect refers to an increase in the success of a treatment when a patient expects a benefit.<...

Cheap Antidepressant Might Help Keep COVID Patients Out of Hospital

• Ernie Mundell and Robert Preidt HealthDay Reporters
• October 28, 2021
• Página completa

A cheap and widely available antidepressant drug called fluvoxamine may reduce COVID-19 patients' risk of serious illness requiring hospitalization, according to a new study.

The trial included almost 1,500 unvaccinated outpatients in Brazil. All of the patients tested p...

Antidepressants Plus Common Painkillers May Raise Bleeding Risk

• Steven Reinberg HealthDay Reporter
• October 26, 2021
• Página completa

Antidepressants called selective serotonin reuptake inhibitors (SSRIs) are a mainstay of depression treatment, but a new study warns that taking common painkillers alongside SSRIs may raise the chances for intestinal bleeding.

In a review of 10 published studies involvin...

Stopping Antidepressants Raises Relapse Risk

• September 29, 2021
• Página completa

People who stop taking antidepressants after long-time use may face a high likelihood of spiraling into depression again, a new study suggests.

British researchers found that among patients who stopped taking their antidepressants because they felt well, 56% relapsed wit...